Spinal Muscular Atrophy Medicine Market Report

Global and Region Spinal Muscular Atrophy Medicine Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：216
  • REPORT CODE：GMM956221
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Spinal Muscular Atrophy Medicine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Spinal Muscular Atrophy Medicinemarket, defines the market attractiveness level of Spinal Muscular Atrophy Medicine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Spinal Muscular Atrophy Medicine industry, describes the types of Spinal Muscular Atrophy Medicine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Spinal Muscular Atrophy Medicine market and the development prospects and opportunities of Spinal Muscular Atrophy Medicine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Spinal Muscular Atrophy Medicine market in Chapter 13.

    By Player:

    • Cytokinetics, Inc 24

    • Genzyme Corporation

    • Ionis Pharmaceuticals, Inc

    • F Hoffmann-La Roche Ltd

    • Vybion, Inc

    • Neurotune AG

    • Neurodyn Inc

    • Novartis AG

    • AveXis, Inc

    • Sarepta Therapeutics, Inc

    • Astellas Pharma Inc

    • WAVE Life Sciences Ltd

    • GMP-Orphan SAS

    • Voyager Therapeutics, Inc

    • Bioblast Pharma Ltd

    • Genethon

    • Longevity Biotech, Inc

    By Type:

    • LMI-070

    • ND-602

    • NT-1654

    • Nusinersen

    • NXD-30001

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Spinal Muscular Atrophy Medicine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Spinal Muscular Atrophy Medicine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Spinal Muscular Atrophy Medicine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Spinal Muscular Atrophy Medicine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Spinal Muscular Atrophy Medicine Market Analysis and Outlook to 2022

    • 7.1 Global Spinal Muscular Atrophy Medicine Consumption (2017-2022)

    • 7.2 United States Spinal Muscular Atrophy Medicine Consumption (2017-2022)

    • 7.3 Europe Spinal Muscular Atrophy Medicine Consumption (2017-2022)

    • 7.4 China Spinal Muscular Atrophy Medicine Consumption (2017-2022)

    • 7.5 Japan Spinal Muscular Atrophy Medicine Consumption (2017-2022)

    • 7.6 India Spinal Muscular Atrophy Medicine Consumption (2017-2022)

    • 7.7 South Korea Spinal Muscular Atrophy Medicine Consumption (2017-2022)

    8 Region and Country-wise Spinal Muscular Atrophy Medicine Market Analysis and Outlook to 2028

    • 8.1 Global Spinal Muscular Atrophy Medicine Consumption Forecast (2022-2028)

    • 8.2 United States Spinal Muscular Atrophy Medicine Consumption Forecast (2022-2028)

    • 8.3 Europe Spinal Muscular Atrophy Medicine Consumption Forecast (2022-2028)

    • 8.4 China Spinal Muscular Atrophy Medicine Consumption Forecast (2022-2028)

    • 8.5 Japan Spinal Muscular Atrophy Medicine Consumption Forecast (2022-2028)

    • 8.6 India Spinal Muscular Atrophy Medicine Consumption Forecast (2022-2028)

    • 8.7 South Korea Spinal Muscular Atrophy Medicine Consumption Forecast (2022-2028)

    9 Global Spinal Muscular Atrophy Medicine Market Outlook by Types and Applications to 2022

    • 9.1 Global Spinal Muscular Atrophy Medicine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global LMI-070 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global ND-602 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global NT-1654 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Nusinersen Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global NXD-30001 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Spinal Muscular Atrophy Medicine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Spinal Muscular Atrophy Medicine Market Outlook by Types and Applications to 2028

    • 10.1 Global Spinal Muscular Atrophy Medicine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global LMI-070 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global ND-602 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global NT-1654 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Nusinersen Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global NXD-30001 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Spinal Muscular Atrophy Medicine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Spinal Muscular Atrophy Medicine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Spinal Muscular Atrophy Medicine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Spinal Muscular Atrophy Medicine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Spinal Muscular Atrophy Medicine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Spinal Muscular Atrophy Medicine Market Competitive Analysis

    • 14.1 Cytokinetics, Inc 24

      • 14.1.1 Cytokinetics, Inc 24 Company Details

      • 14.1.2 Cytokinetics, Inc 24 Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Cytokinetics, Inc 24 Spinal Muscular Atrophy Medicine Product and Service

    • 14.2 Genzyme Corporation

      • 14.2.1 Genzyme Corporation Company Details

      • 14.2.2 Genzyme Corporation Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Product and Service

    • 14.3 Ionis Pharmaceuticals, Inc

      • 14.3.1 Ionis Pharmaceuticals, Inc Company Details

      • 14.3.2 Ionis Pharmaceuticals, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Ionis Pharmaceuticals, Inc Spinal Muscular Atrophy Medicine Product and Service

    • 14.4 F Hoffmann-La Roche Ltd

      • 14.4.1 F Hoffmann-La Roche Ltd Company Details

      • 14.4.2 F Hoffmann-La Roche Ltd Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 F Hoffmann-La Roche Ltd Spinal Muscular Atrophy Medicine Product and Service

    • 14.5 Vybion, Inc

      • 14.5.1 Vybion, Inc Company Details

      • 14.5.2 Vybion, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Vybion, Inc Spinal Muscular Atrophy Medicine Product and Service

    • 14.6 Neurotune AG

      • 14.6.1 Neurotune AG Company Details

      • 14.6.2 Neurotune AG Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Neurotune AG Spinal Muscular Atrophy Medicine Product and Service

    • 14.7 Neurodyn Inc

      • 14.7.1 Neurodyn Inc Company Details

      • 14.7.2 Neurodyn Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Neurodyn Inc Spinal Muscular Atrophy Medicine Product and Service

    • 14.8 Novartis AG

      • 14.8.1 Novartis AG Company Details

      • 14.8.2 Novartis AG Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novartis AG Spinal Muscular Atrophy Medicine Product and Service

    • 14.9 AveXis, Inc

      • 14.9.1 AveXis, Inc Company Details

      • 14.9.2 AveXis, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AveXis, Inc Spinal Muscular Atrophy Medicine Product and Service

    • 14.10 Sarepta Therapeutics, Inc

      • 14.10.1 Sarepta Therapeutics, Inc Company Details

      • 14.10.2 Sarepta Therapeutics, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sarepta Therapeutics, Inc Spinal Muscular Atrophy Medicine Product and Service

    • 14.11 Astellas Pharma Inc

      • 14.11.1 Astellas Pharma Inc Company Details

      • 14.11.2 Astellas Pharma Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Astellas Pharma Inc Spinal Muscular Atrophy Medicine Product and Service

    • 14.12 WAVE Life Sciences Ltd

      • 14.12.1 WAVE Life Sciences Ltd Company Details

      • 14.12.2 WAVE Life Sciences Ltd Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 WAVE Life Sciences Ltd Spinal Muscular Atrophy Medicine Product and Service

    • 14.13 GMP-Orphan SAS

      • 14.13.1 GMP-Orphan SAS Company Details

      • 14.13.2 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Product and Service

    • 14.14 Voyager Therapeutics, Inc

      • 14.14.1 Voyager Therapeutics, Inc Company Details

      • 14.14.2 Voyager Therapeutics, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Voyager Therapeutics, Inc Spinal Muscular Atrophy Medicine Product and Service

    • 14.15 Bioblast Pharma Ltd

      • 14.15.1 Bioblast Pharma Ltd Company Details

      • 14.15.2 Bioblast Pharma Ltd Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Bioblast Pharma Ltd Spinal Muscular Atrophy Medicine Product and Service

    • 14.16 Genethon

      • 14.16.1 Genethon Company Details

      • 14.16.2 Genethon Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Genethon Spinal Muscular Atrophy Medicine Product and Service

    • 14.17 Longevity Biotech, Inc

      • 14.17.1 Longevity Biotech, Inc Company Details

      • 14.17.2 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Spinal Muscular Atrophy Medicine

    • Figure Spinal Muscular Atrophy Medicine Picture

    • Table Global Spinal Muscular Atrophy Medicine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Spinal Muscular Atrophy Medicine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Spinal Muscular Atrophy Medicine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Spinal Muscular Atrophy Medicine Consumption by Country (2017-2022)

    • Figure United States Spinal Muscular Atrophy Medicine Consumption and Growth Rate (2017-2022)

    • Table Europe Spinal Muscular Atrophy Medicine Consumption and Growth Rate (2017-2022)

    • Figure China Spinal Muscular Atrophy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Japan Spinal Muscular Atrophy Medicine Consumption and Growth Rate (2017-2022)

    • Figure India Spinal Muscular Atrophy Medicine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Spinal Muscular Atrophy Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Spinal Muscular Atrophy Medicine Consumption Forecast by Country (2022-2028)

    • Figure United States Spinal Muscular Atrophy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Spinal Muscular Atrophy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Spinal Muscular Atrophy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Spinal Muscular Atrophy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Spinal Muscular Atrophy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Spinal Muscular Atrophy Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global LMI-070 Consumption and Growth Rate (2017-2022)

    • Figure Global ND-602 Consumption and Growth Rate (2017-2022)

    • Figure Global NT-1654 Consumption and Growth Rate (2017-2022)

    • Figure Global Nusinersen Consumption and Growth Rate (2017-2022)

    • Figure Global NXD-30001 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global LMI-070 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ND-602 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NT-1654 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nusinersen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NXD-30001 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Spinal Muscular Atrophy Medicine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Spinal Muscular Atrophy Medicine Export by Region (Top 5 Countries) (2017-2028)

    • Table Cytokinetics, Inc 24 (Foundation Year, Company Profile and etc.)

    • Table Cytokinetics, Inc 24 Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cytokinetics, Inc 24 Spinal Muscular Atrophy Medicine Product and Service

    • Table Genzyme Corporation (Foundation Year, Company Profile and etc.)

    • Table Genzyme Corporation Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genzyme Corporation Spinal Muscular Atrophy Medicine Product and Service

    • Table Ionis Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Ionis Pharmaceuticals, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ionis Pharmaceuticals, Inc Spinal Muscular Atrophy Medicine Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Spinal Muscular Atrophy Medicine Product and Service

    • Table Vybion, Inc (Foundation Year, Company Profile and etc.)

    • Table Vybion, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vybion, Inc Spinal Muscular Atrophy Medicine Product and Service

    • Table Neurotune AG (Foundation Year, Company Profile and etc.)

    • Table Neurotune AG Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurotune AG Spinal Muscular Atrophy Medicine Product and Service

    • Table Neurodyn Inc (Foundation Year, Company Profile and etc.)

    • Table Neurodyn Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurodyn Inc Spinal Muscular Atrophy Medicine Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Spinal Muscular Atrophy Medicine Product and Service

    • Table AveXis, Inc (Foundation Year, Company Profile and etc.)

    • Table AveXis, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table AveXis, Inc Spinal Muscular Atrophy Medicine Product and Service

    • Table Sarepta Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Sarepta Therapeutics, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sarepta Therapeutics, Inc Spinal Muscular Atrophy Medicine Product and Service

    • Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc Spinal Muscular Atrophy Medicine Product and Service

    • Table WAVE Life Sciences Ltd (Foundation Year, Company Profile and etc.)

    • Table WAVE Life Sciences Ltd Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table WAVE Life Sciences Ltd Spinal Muscular Atrophy Medicine Product and Service

    • Table GMP-Orphan SAS (Foundation Year, Company Profile and etc.)

    • Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Product and Service

    • Table Voyager Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Voyager Therapeutics, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Voyager Therapeutics, Inc Spinal Muscular Atrophy Medicine Product and Service

    • Table Bioblast Pharma Ltd (Foundation Year, Company Profile and etc.)

    • Table Bioblast Pharma Ltd Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioblast Pharma Ltd Spinal Muscular Atrophy Medicine Product and Service

    • Table Genethon (Foundation Year, Company Profile and etc.)

    • Table Genethon Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genethon Spinal Muscular Atrophy Medicine Product and Service

    • Table Longevity Biotech, Inc (Foundation Year, Company Profile and etc.)

    • Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US